Michael Baker | |
---|---|
Born | Michael Allen Baker January 24, 1943 Toronto, Ontario, Canada |
Awards | Order of Canada Order of Ontario |
Michael Allen Baker, CM OOnt (born January 24, 1943) is a Canadian physician, academic, and cancer researcher. He is Rose Family Chair in Medicine, [1] former Physician-in-Chief, University Health Network and Professor of Medicine at the University of Toronto. His research has helped to improve the understanding of human leukemia and other cancers. [2]
Born in Toronto, Ontario, Baker attended Oakwood Collegiate Institute, [3] then received his M.D. from the University of Toronto in 1966. He received his diploma from the National Board of Medical Examiners in 1967 and is a Fellow of the Royal College of Physicians and Surgeons of Canada specializing in Hematology and Internal Medicine. In 1982, he joined the University of Toronto as a Professor of Medicine. In 1992, he was made Physician-in-Chief of the Toronto General Hospital. [4]
He was president of the National Cancer Institute of Canada for 3 years and a board member of the Canadian Cancer Society for 5 years. [2] In 2008, he was appointed by the Ontario Ministry of Health and Long-Term Care Executive Lead - Patient Safety, to oversee the government's patient safety agenda. [5] In 2011, he was elected Chair of the Board of the Institute of Evaluative Sciences (ICES).
In 2008, he was made a Member of the Order of Canada "for his contributions to health care in Canada, notably for his work in developing an innovative, integrated medical care program for cancer patients and for his leadership in the area of infectious disease control". [6] In 2009, he was made a member of the Order of Ontario in recognition for being "a leading researcher whose work has led to a better understanding of leukemia and other cancers". [7] In 2006, he was made a Fellow of the Canadian Academy of Health Sciences. [8] He was awarded the 125th Anniversary of the Confederation of Canada Medal and the Queen Elizabeth II Golden Jubilee Medal. [2]
Dafydd Rhys "David" Williams is a Canadian physician, public speaker, author and retired CSA astronaut. Williams was a mission specialist on two Space Shuttle missions. His first spaceflight, STS-90 in 1998, was a 16-day mission aboard Space Shuttle Columbia dedicated to neuroscience research. His second flight, STS-118 in August 2007, was flown by Space Shuttle Endeavour to the International Space Station. During that mission he performed three spacewalks, becoming the third Canadian to perform a spacewalk and setting a Canadian record for total number of spacewalks. These spacewalks combined for a total duration of 17 hours and 47 minutes.
James Jude Orbinski is a Canadian physician, humanitarian activist, author, and scholar in global health. He is a professor in the Faculty of Health Science, and was founding director of the Dahdaleh Institute of Global Health Research at York University in Toronto, Ontario, Canada.
The Hospital for Sick Children (HSC), corporately branded as SickKids, is a major pediatric teaching hospital located on University Avenue in Toronto, Ontario, Canada. Affiliated with the Faculty of Medicine of the University of Toronto, the hospital was ranked the top pediatric hospital in the world by Newsweek in 2021.
Frederick Hans Lowy, is a Canadian medical educator and former President and Vice-Chancellor of Concordia University.
The Temerty Faculty of Medicine is the medical school of the University of Toronto. Founded in 1843, the faculty is based in Downtown Toronto and is one of Canada's oldest institutions of medical studies, being known for the discovery of insulin, stem cells and the site of the first single and double lung transplants in the world.
University Health Network (UHN) is a public research and teaching hospital network in Toronto, Ontario, Canada. It is affiliated with the University of Toronto, and is the largest health research organization in Canada, ranking first in Canada for total research funding. It was named Canada's top research hospital by Research Infosource from 2015 to 2022. The network includes three acute care hospitals – Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre – West Park Healthcare Centre, the Toronto Rehabilitation Institute, and The Michener Institute, a post-secondary institution granting diplomas and certificates in health sciences and leadership. In the 2019-2020 fiscal year, there were over 39,000 acute inpatient stays and close to 121,000 emergency department visits across the three acute care hospitals. Newsweek has consistently named UHN's Toronto General Hospital as among the world's top hospitals, most recently ranking Toronto General as the world's 3rd best hospital in 2024, and first in Canada.
Christopher David Naylor, is a Canadian physician, medical researcher and former president of the University of Toronto. He is ICES scientist emeritus and founding CEO. In 2016, he was inducted into the Canadian Medical Hall of Fame.
Tak Wah Mak, is a Canadian medical researcher, geneticist, oncologist, and biochemist. He first became widely known for his discovery of the T-cell receptor in 1983 and pioneering work in the genetics of immunology. In 1995, Mak published a landmark paper on the discovery of the function of the immune checkpoint protein CTLA-4, thus opening the path for immunotherapy/checkpoint inhibitors as a means of cancer treatment. Mak is also the founder of Agios Pharmaceuticals, whose lead compound, IDHIFA®, was approved by the FDA for acute myeloid leukemia in August 2017, becoming the first drug specifically targeting cancer metabolism to be used for cancer treatment. He has worked in a variety of areas including biochemistry, immunology, and cancer genetics.
The College of Physicians and Surgeons of Ontario (CPSO) is the regulatory college for medical doctors in Ontario, Canada.
Charles H. Hollenberg was a Canadian physician, educator and researcher.
Women's College Hospital is a teaching hospital in Toronto, Ontario, Canada. It is located in downtown Toronto at the north end of Hospital Row, a section of University Avenue where several major hospitals are located. It currently functions as an independent ambulatory care hospital.
John Edgar Dick is Canada Research Chair in Stem Cell Biology, Senior Scientist at the Princess Margaret Cancer Centre, University Health Network and Professor in the Department of Molecular Genetics at the University of Toronto in Canada. Dick is credited with first identifying cancer stem cells in certain types of human leukemia. His revolutionary findings highlighted the importance of understanding that not all cancer cells are the same and thus spawned a new direction in cancer research. Dick is also known for his demonstration of a blood stem cell's ability to replenish the blood system of a mouse, his development of a technique to enable an immune-deficient mouse to carry and produce human blood, and his creation of the world's first mouse with human leukemia.
David George Gratzer is a physician, columnist, author, Congressional expert witness; he was a senior fellow at both the Manhattan Institute and the Montreal Economic Institute. Though he has written essays on topics as diverse as obesity and political campaigns, he is best known for his first book, published by ECW Press, when he was just 24: Code Blue: Reviving Canada's Health Care System. That book won the Donner Prize established by the Donner Canadian Foundation and was a national bestseller in his native Canada. Gratzer is a critic of the Canadian health care system, and of U.S. President Barack Obama's health care reform proposals. Gratzer was health care policy advisor to Rudy Giuliani's 2008 presidential campaign.
The Canadian College of Naturopathic Medicine (CCNM) is a private, not-for-profit institution with two campus locations: the CCNM -Toronto Campus in Toronto, Ontario, Canada, and the CCNM -Boucher Campus in New Westminster, British Columbia, Canada.
Brian J. Druker is a physician-scientist at Oregon Health & Science University (OHSU), in Portland, Oregon. He is the director of OHSU's Knight Cancer Institute, JELD-WEN Chair of Leukemia Research, Associate Dean for Oncology in the OHSU School of Medicine, and professor of medicine.
Allen Charles Edward Eaves is the co-founding Director of the Terry Fox Laboratory for Hematology/Oncology Research, which over a 25-year period (1981–2006) he grew into an internationally recognized centre for the study of leukemia and stem cell research. His own research on chronic myelogenous leukemia (CML) has led the way to a new understanding of the disease. As Head of Hematology at the British Columbia Cancer Agency and the University of British Columbia for 18 years (1985–2003) he engineered the building of one of the first and largest bone marrow transplant programs in Canada. In recognition of his research accomplishments and leadership in moving basic science discoveries in stem cell biology into the clinic, he was elected President of the International Society of Cellular Therapy (1995–1997), Treasurer of the Foundation for the Accreditation of Cellular Therapy (1995–2002) and President of the American Society of Blood and Marrow Transplantation (1999–2000). In 2003 he was awarded the prestigious R. M. Taylor Medal by the Canadian Cancer Society and the National Cancer Institute of Canada.
Alan Bernstein is Professor Emeritus at the University of Toronto and President Emeritus of the Canadian Institute for Advanced Research (CIFAR), where he served as President and CEO from 2012 to 2022. A Distinguished Fellow at the Munk School of Global Affairs and Public Policy, he is also a Fellow and Member of the Standing Committee for Science Planning at the International Science Council (2022-2025). Canadian Bernstein is recognized as a leader in health research, science policy, mentorship and organizational leadership.
Wendy Levinson MD is a Canadian physician and academic. She is the Chair of Choosing Wisely Canada, "a campaign to help physicians and patients engage in conversations about unnecessary tests, treatments and procedures". She is also Professor of Medicine at the University of Toronto.
Nancy Baxter is a Canadian surgeon who is a professor and the Head of Melbourne University's School of Population and Global Health, while continuing to maintain her appointment as Professor of Surgery in the Department of Surgery and the Institute of Health Policy, Management and Evaluation at the University of Toronto. She is a scientist with the Li Ka Shing Knowledge Institute and is a senior scientist in the Cancer Theme Group with the Institute for Clinical Evaluative Sciences (ICES). Baxter has board certifications through the American Board of Surgery (2000) and the American Board of Colon and Rectal Surgery (2002). She is a Fellow of the American College of Surgeons, the Royal College of Physicians and Surgeons of Canada, and the American Society of Clinical Oncology.
Catharine Isobel Whiteside, CM, FRCPC, FCAHS is a Canadian physician and medical researcher. She is Director, Strategic Partnerships of Diabetes Action Canada and Chair of the board of the Banting Research Foundation. Whiteside is the former Dean of the Faculty of Medicine at the University of Toronto.